Patent · US Active

Composition and method for the diagnosis and treatment of iron-related disorders

US10822403B2 · kind B2 · utility

2Cited by

113References

14Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Bernhard Mueller · Neustadt, DE
Andreas Popp · Ludwigshafen, DE
Jennifer M. Perez · Worcester, US

Key dates

Filing date	Nov 2, 2018
Grant date	Nov 3, 2020
Priority date	—
Expiry date	Nov 2, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are methods of using the antibodies that bind to RGMc to treat and diagnose iron-related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.